NCT07517393 Study of Collection and Analysis of Clinical, Anamnestic, Functional, Biological Data Through the Support of Artificial Intelligence to Evaluate the Possibility of Defining a Digital Twin of the Lung (LUCE)
| NCT ID | NCT07517393 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Casa di Cura Dott. Pederzoli |
| Condition | Thoracic Neoplasm |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2026-04 |
| Primary Completion | 2036-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2026-04 with a primary completion date of 2036-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This research study aims to retrospectively and prospectively analyze the clinical, anamnestic, functional, biological data of patients who have performed or will perform non-contrast chest photon count CT. The use of contrast medium is evaluated by the physician. Main objective The study aims to understand how many people who undergo non-contrast photon-counting chest CT have: lung nodules, chest tumors, and other non-cancerous lung diseases. Secondary objectives * Analyze the data with the help of artificial intelligence to create a "digital twin" of the lung, that is, a virtual copy of the lung that allows you to study and simulate the behavior of the lung for research and analysis purposes, without directly intervening on the patient. * Follow any suspicious lung changes over time to understand how they change and whether they are linked to clinical, biological, or laboratory parameters. The enrollment phase will last 12 months and will begin with the approval of the study. At this stage, clinical data already present in the patient's medical record and data relating to the photon count CT examination will be collected. After the enrollment phase, the patient will be observed for a further total duration of 10 years: in particular, a follow-up visit will be arranged at two, five and ten years. More specifically, if there are no radiological elements that require scheduling a visit to the center, the patient will be contacted by telephone for a telematic update of the data. If, however, pulmonary alterations are identified during the study, the patient will be referred to the Reference Operating Unit, as per clinical practice, to continue with the most appropriate personalized diagnostic-therapeutic process. In these cases, the patient will be contacted by telephone and an appointment with the institution will be suggested.
Eligibility Criteria
Inclusion Criteria: * Men or women aged ≥ 18 years who will perform a smdc photon count chest CT scan * written informed consent. Exclusion Criteria: * Lack of information regarding anamnestic data * any reason why the investigator deems the patient unenrollable in the practice.
Frequently Asked Questions
Who can join the NCT07517393 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Thoracic Neoplasm. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07517393 currently recruiting?
Yes, NCT07517393 is actively recruiting participants. Visit ClinicalTrials.gov or contact Casa di Cura Dott. Pederzoli to inquire about joining.
Where is the NCT07517393 trial being conducted?
This trial is being conducted at Peschiera del Garda, Italy.
Who is sponsoring the NCT07517393 clinical trial?
NCT07517393 is sponsored by Casa di Cura Dott. Pederzoli. The trial plans to enroll 1,000 participants.